Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan for Early Treatment of Severe Sepsis
NCT01992796Phase 3Unknown
- Sponsor
- University of Salerno
- Start
- Jan 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of irbesartan in sepsis, sponsored by University of Salerno. Status: unknown.
02
Drugs
irbesartan
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT01992796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01992796.